Vaccinex Sees Mixed Signals In Huntington’s Study

Pepinemab Missed Key Endpoints In Phase II Trial

 
• By Joseph Haas
  
Hand flip wooden cube with the word PLAN A to PLAN B on white background. Business concept
With mixed data in Huntington's, Vaccinex turns attention to Alzheimer's
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D